Abstract:Background Epigenetic alternation is a common contributing factor to neoplastic transformation. Although previous studies have reported a cluster of aberrant promoter methylation changes associated with silencing of tumor suppressor genes, little is known concerning their sequential DNA methylation changes during the carcinogenetic process. The aim of the present study was to address a genome-wide search for identifying potentially important methylated changes and investigate the onset and pattern of methylation changes during the progression of colorectal neoplasia. Methods A three-phase design was employed in this study. In the screening phase, DNA methylation profile of 12 pairs of colorectal cancer (CRC) and adjacent normal tissues was analyzed by using the Illumina MethylationEPIC BeadChip. Significant CpG sites were selected based on a cross-validation analysis from The Cancer Genome Atlas (TCGA) database. Methylation levels of candidate CpGs were assessed using pyrosequencing in the training dataset (tumor lesions and adjacent normal tissues from 46 CRCs) and the validation dataset (tumor lesions and paired normal tissues from 13 hyperplastic polyps, 129 adenomas, and 256 CRCs). A linear mixed-effects model was used to examine the incremental changes of DNA methylation during the progression of colorectal neoplasia. Results The comparisons between normal and tumor samples in the screening phase revealed an extensive CRC-specific methylomic pattern with 174,006 (21%) methylated CpG sites, of which 22,232 (13%) were hyermethylated and 151,774 (87%) were hypomethylated. Hypermethylation mostly occurred in CpG islands with an overlap of gene promoters, while hypomethylation tended to be mapped far away from functional regions. Further cross validation analysis from TCGA dataset confirmed 265 hypermethylated promoters coupling with downregulated gene expression. Among which, hypermethylated changes in MEEPD2 promoter was successfully replicated in both training and validation phase. Significant hypermethylation appeared since precursor lesions with an extensive modification in CRCs. The linear mixed-effects modeling analysis found that a cumulative pattern of MPPED2 methylation changes from normal mucosa to hyperplastic polyp to adenoma, and to carcinoma ( P < 0.001). Conclusions Our findings indicate that epigenetic alterations of MPPED2 promoter region appear sequentially during the colorectal neoplastic progression. It might be able to serve as a promising biomarker for early diagnosis and stage surveillance of colorectal tumorigenesis.

Methylation Status of ADAM12 Promoter Are Associated with Its Expression Levels in Colorectal Cancer.

The expression of ADAMTS14 is regulated by promoter DNA methylation and is associated with poor prognosis in colorectal cancer

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis

Expression of ADAMTS12 in Colorectal Cancer-Associated Stroma Prevents Cancer Development and is a Good Prognostic Indicator of Colorectal Cancer

Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

Hypermethylation of Protocadherin Γ Subfamily A12 and Solute Carrier Family 19 A 1 Promoters Contributes to the Occurrence and Metastasis of Colorectal Cancer

High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers

High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers.

APC Promoter Methylation in Gastrointestinal Cancer

Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer

Hypermethylation of APC2 is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer

The Expression Of Adam23 And Its Correlation With Promoter Methylation In Non-Small-Cell Lung Carcinoma

The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients

Integrated Analyses of Multi-Omics Reveal Global Patterns of Methylation and Hydroxymethylation and Screen the Tumor Suppressive Roles of HADHB in Colorectal Cancer

Hypermethylation Of The 16q23.1 Tumor Suppressor Gene Adamts18 In Clear Cell Renal Cell Carcinoma

Early results of the integrative epigenomic-transcriptomic landscape of colorectal adenoma and cancer

Inactivation Of Adamts18 By Aberrant Promoter Hypermethylation Contribute To Lung Cancer Progression

Identification of Regulatory Role of DNA Methylation in Colon Cancer Gene Expression Via Systematic Bioinformatics Analysis

Quantitative Assessment Of Akap12 Promoter Methylation In Colorectal Cancer Using Methylation-Sensitive High Resolution Melting Correlation With Duke'S Stage